You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Development lightmap rendering technology to advance infrared simulation capabilities for training applications
SBC: JRM ENTERPRISES, INC. Topic: AF17AT012JRM Technologies proposes a new CUDA-based 3D thermal signature physics engine which combines real-time raytracing (photon-mapping) and localized temperature maps that together with new GPU shaders will better model the transient interactive coupling of dynamic thermal sources with affected 3D scene elements. To support this new physics engine, JRM proposes to leverage and extend its proven real- ...
STTR Phase I 2017 Department of DefenseAir Force -
Knowledge and Usage of Lactation using Education and Advice from Support Network KULEA NET
SBC: BENTEN TECHNOLOGIES, INC. Topic: NIMHDPROJECT SUMMARY ABSTRACT Breastfeeding has the potential to reduce health disparities associated with infant mortality and morbidity Breastfeeding rates by ethnicity in the United States show a marked disparity in African American AA women as compared to other groups Barriers to breastfeeding are complex with literature citing a lack of knowledge poor family and social support inhibiting soc ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
A Novel Scaffold to Promote Skin Regeneration
SBC: FirstString Research, Inc Topic: NIAMSPROJECT SUMMARY Dermal scarring affects more than million people worldwide annually over million people are injured in motor vehicle accidents over million patients are severely burned and thousands of warriors are wounded in military blasts In severe burns more than of patients develop hypertrophic scar contraction which leads to hypertrophic scar contractures HSc HSc a ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Self expanding hydrogel for pelvic brachytherapy a novel method for vaginal packing and customized radiation therapy
SBC: BrachyFoam, LLC Topic: 102This proposal aims to develop a polymer hydrogel strategy that can be used to improve the clinical care of patients receiving brachytherapy for gynecological cancers The biocompatible hydrogel will form in situ after being injected into the vaginal space and later removed by instillation of water to soften the hydrogel for easy extraction This Phase I proposal focuses on optimizing the polymer ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Therapeutic disruption of Connexin mediated microtubule regulation to target glioblastoma cancer stem cells
SBC: Acomhal Research, Inc. Topic: 100Project Summary Glioblastoma GBM is one of the most lethal incurable human diseases Even with aggressive therapies including surgical resection followed by radiotherapy and chemotherapy using temozolomide TMZ the median survival for GBM patients is only months In fact GBM cancer cells are highly infiltrative and comprise a sub population of glioma stem cells GSCs with tumorigenic pro ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
GRIM for head and neck cancer therapy
SBC: GLYCOMANTRA INC Topic: 102Project Summary Many clinical and preclinical studies demonstrated that interferons IFNs exert a superior anti tumor effect when combined with retinoids a class of vitamin A metabolites We identified a novel tumor suppressor Gene associated with Retinoid IFN induced Mortality GRIM by a genome wide knockdown strategy In our recent publication in the PNAS we have shown that GRIM g ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Lipid Enhanced Nano Sensors LENS for lead and mercury detection in water
SBC: ZANSORS LLC Topic: NIEHSAbstract This Phase I application aims to determine the feasibility of using lipid enhanced nanosensor LENS arrays for smart phone based detection of lead Pb and mercury Hg in drinking water at concentrations above FDA allowable levels LENS arrays are composed of fluid lipid multilayer diffraction gratings on surfaces The fluid nature of these arrays has two advantages reagents can ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health -
Semantic Parsing and role Labeling In Combination Effort (SPLICE)
SBC: DECISIVE ANALYTICS CORPORATION Topic: DTRA14B003To Counter Weapons of Mass Destruction (CWMD), DTRA must analyze data from numerous sources about a diverse set of technologies and activities. The extreme diversity in content and the volume of DTRAs data combine to produce one of the most challenging analysis problems in the government. The CWMD mission therefore requires deep analysis - an in-depth understanding of all available data and correl ...
STTR Phase II 2017 Department of DefenseDefense Threat Reduction Agency -
High Strain Composite Testing Methodologies
SBC: MC Technologies LLC Topic: AF17AT019An innovative loading stage design based on the principle of eccentric loading is proposed for mechanical testing of thin composites to impart precise mixtures uniaxial and bending stresses. In contrast to alternative designs, the mechanism is fully compatible with advanced experimental techniques such as three-dimensional digital image correlation (3D-DIC) strain measurements and in situ micro X- ...
STTR Phase I 2017 Department of DefenseAir Force -
Polo box PLK Inhibitors Target Tumors Resistant to ATP Competitive Compounds
SBC: PPI PHARMACEUTICALS, LLC Topic: NCIPolo like kinase PLK is a central player in regulating entry into and progression through mitosis Many studies have validated PLK as an anti tumor drug target and its inhibition is potently anti proliferative to cancer cells However recent data suggests that there are two major disadvantages of the conventional approach to blocking the kinase activity of PLK First both general kinome ...
STTR Phase I 2017 Department of Health and Human ServicesNational Institutes of Health